Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 30, 2026 Crypto Market Update: Iran War Drives Oil Derivatives Boom on Crypto Exchange March 30, 2026 Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 30, 2026
Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 30, 2026
Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 30, 2026